Heat‐treated Limosilactobacillus fermentumLM1020 with menthol, salicylic acid, and panthenol promotes hair growth and regulates hair scalp microbiome balance in androgenetic alopecia: A double‐blind, randomized and placebo‐controlled clinical trial

Abstract

AbstractBackgroundAndrogenetic alopecia (AGA) is a common and chronic problem characterized by hair follicle miniaturization.AimsIn this study, heat‐treated Limosilactobacillus fermentum LM1020 (HT‐LM1020) was investigated in human follicle dermal papilla cell (HFDPC), scalp tissue, and clinical trials for patients with AGA.Patients/MethodsCell proliferation and the expression of cyclins and cyclin‐dependent kinases (CDKs) were measured in HFDPC. The relative gene expression of 5α‐reductase and growth factors were investigated in hair scalp. This double‐blind, randomized, placebo‐controlled clinical trial was conducted over 24 weeks. Primary efficacy was evaluated by measuring hair density, and secondary efficacy was assessed by experts and self‐assessment. Changes in the microbiota of the hair scalps were analyzed using 16S metagenome amplicon sequencing.ResultsHT‐LM1020 promoted cell growth (p < 0.001) and cyclin B1 expression, and it reduced 5α‐reductase and induced fibroblast growth factor 7 (FGF7), FGF10, and epithelial growth factor7 (EGF7) (p < 0.001). In the clinical trial, the experimental group demonstrated an increase in hair density from 133.70 to 148.87 n/cm2 at Week 24 (p < 0.001), while also expressing satisfaction with their hair density, reduced hair loss, and hairline. At Week 24, the total ratio of lactic acid bacteria operational taxonomic unit (OTU) in the scalp increased from 6.65% to 26.19%. At the same period, placebo‐controlled group decreased Staphylococcus caprae OTU from 77.95% to 14.57% while experimental group decreased from 65.80% to 41.02%.ConclusionsThese present results showed that HT‐LM1020 was a co‐effector of ingredients for anti‐hair loss contributing to cell proliferation and the expression of CDKs.